25 May 2013
Keywords: bayer, oral, fludara, gets, mhlw, approval, schering
Article | 05 February 2007
Bayer Schering Pharma, the health care division of Germany's Bayer AG, says that the oral formulation of its anticancer agent ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 February 2007
12 February 2007
24 May 2013
© 2013 thepharmaletter.com